null Skip to main content

Saffron Research Snapshot

Research Snapshot

Saffron

A synthesis of the peer-reviewed evidence for Saffron across mood, cognition, neuroprotection and oxidation, graded by scientific consensus and reviewed by our Scientific Advisory Board.

62 studies analyzed 4 benefit areas Reviewed by the SAB Updated Jul 2026

See the Research

Mood

Can Saffron improve mood?

Evidence from 10 studies

Yes
80%
8 studies
Possibly
20%
2 studies
No
0%
0 studies

What the research shows

Saffron appears to be a promising natural alternative for improving mood and supporting healthy mood and calmness. It is effective in both human research and general populations, with a favorable safety profile. However, further research is needed to confirm these findings across diverse populations and to fully understand its mechanisms of action.

View the top studies
affron® a novel saffron extract (Crocus sativus L.) improves mood in healthy adults over 4 weeks in a double-blind, parallel, randomized, placebo-controlled clinical trial.

Complementary therapies in medicine | Graham Kell et al. | 60 | 2017

Randomized Control Trial (RCT)

Affron®, a saffron extract, significantly decreased negative mood and symptoms related to stress and anxiety at a 28mg/day dose.

Effects of Saffron Extract Supplementation on Mood, Well-Being, and Response to a Psychosocial Stressor in Healthy Adults: A Randomized, Double-Blind, Parallel Group, Clinical Trial

Frontiers in Nutrition | P. Jackson et al. | 22 | 2021

Randomized Control Trial (RCT)

Saffron extract appears to improve subclinical depressive symptoms in healthy individuals and may contribute to increased resilience against stress-related psychiatric disorders.

Saffron in the treatment of depression, anxiety and other mental disorders: Current evidence and potential mechanisms of action.

Journal of affective disorders | Mojtaba Shafiee et al. | 107 | 2018

Rigorous Journal , Highly Cited , Systematic Review

Saffron may exert antidepressant effects and represents an efficacious and safe treatment for depression.

affron®, a standardised extract from saffron (Crocus sativus L.) for the treatment of youth anxiety and depressive symptoms: A randomised, double-blind, placebo-controlled study.

Journal of affective disorders | Adrian L. Lopresti et al. | 43 | 2018

Randomized Control Trial (RCT) , Rigorous Journal

Saffron extract (affron®) improved anxiety and depressive symptoms in youth with mild-to-moderate symptoms, according to adolescent self-reports.

Cognition

Does Saffron improve cognitive function?

Evidence from 17 studies

Yes
53%
9 studies
Possibly
29%
5 studies
No
18%
3 studies

What the research shows

Saffron shows promise as a natural treatment for improving cognitive function, particularly in human studies. Its effectiveness is comparable to conventional drugs, with a favorable safety profile. However, further large-scale, high-quality studies are needed to confirm these findings and establish saffron as a standard treatment option for cognitive function.

View the top studies
Association between chronic stress and Alzheimer's disease: Therapeutic effects of Saffron.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | Mohammad Saeedi et al. | 34 | 2020

Systematic Review

Saffron and its main component crocin are effective against chronic stress-induced cognitive dysfunction and oxidative stress, and slowed cognitive decline in Alzheimer's disease.

Memory enhancing effects of saffron in aged mice are correlated with antioxidant protection

Behavioural Brain Research | Magdalini A. Papandreou et al. | 194 | 2011

Non-Randomized Control Trial , Animal Trial , Highly Cited , Controlled experimental study

Saffron administration in mice led to significant improvement in learning and memory, accompanied by reduced lipid peroxidation products and higher antioxidant activity.

Neuroprotective effects of saffron on the late cerebral ischemia injury through inhibiting astrogliosis and glial scar formation in rats.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | Kai Zhong et al. | 20 | 2020

Randomized Control Trial (RCT) , Animal Trial , Rigorous Journal

Saffron ameliorated anxiety-like state and cognitive dysfunction in rats after cerebral ischemia.

Association of Crocus sativus with Cognitive Dysfunctions and Alzheimer’s Disease: A Systematic Review

Biointerface Research in Applied Chemistry | M. Talebi et al. | 13 | 2020

Systematic Review

Saffron and its major constituents have remarkable properties on memory and cognitive deficiency, suggesting potential support for cognitive function.

Neuroprotection

Can Saffron offer neuroprotection?

Evidence from 19 studies

Yes
79%
15 studies
Possibly
21%
4 studies
No
0%
0 studies

What the research shows

Saffron exhibits promising neuroprotective properties through its antioxidant, anti-inflammatory, and neurotransmitter-modulating effects. These findings suggest its potential as a supplementary agent for cognitive and mental function. Further research, particularly clinical trials, is needed to fully understand and harness its potential.

View the top studies
Protective properties of the aqueous extract of saffron (Crocus sativus L.) in ischemic stroke, randomized clinical trial.

Journal of ethnopharmacology | Mostafa Asadollahi et al. | 19 | 2019

Randomized Control Trial (RCT)

Saffron extract has short and long-term neuroprotective effects on ischemic stroke in humans.

Neuroprotective effects of saffron on the late cerebral ischemia injury through inhibiting astrogliosis and glial scar formation in rats.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | Kai Zhong et al. | 20 | 2020

Randomized Control Trial (RCT) , Animal Trial , Rigorous Journal

Saffron exerted neuroprotective effects on late cerebral ischemia by attenuating astrogliosis and glial scar formation after ischemic injury.

Saffron: Chemical Composition and Neuroprotective Activity

Molecules | M. Maggi et al. | 30 | 2020

Systematic Review

Saffron's ability to cope with retinal neurodegeneration is related to the presence of specific crocins and the contribution of other saffron components.

Saffron pre-treatment offers neuroprotection to Nigral and retinal dopaminergic cells of MPTP-Treated mice.

Journal of Parkinson's disease | Sivaraman Purushothuman et al. | 58 | 2013

Non-Randomized Control Trial , Animal Trial , Rigorous Journal

Saffron pre-treatment saved many dopaminergic cells of the substantia nigra pars compacta (SNc) and retina from parkinsonian (MPTP) insult.

Oxidation

Can Saffron help maintain balanced oxidation levels?

Evidence from 16 studies

Yes
88%
14 studies
Possibly
13%
2 studies
No
0%
0 studies

What the research shows

Saffron is effective in maintaining balanced oxidation levels by reducing oxidative stress markers and enhancing antioxidant capacity. Its active compounds, such as crocin and safranal, play a crucial role in these effects, making saffron a promising supplement for managing oxidative stress-related health issues. Further research is needed to fully understand its long-term efficacy and safety.

View the top studies
Effects of saffron supplementation on oxidative/antioxidant status and severity of disease in ulcerative colitis patients: A randomized, double‐blind, placebo‐controlled study

Phytotherapy Research | N. Tahvilian et al. | 18 | 2020

Randomized Control Trial (RCT)

Saffron supplementation significantly increased serum levels of total antioxidant capacity, superoxide dismutase, and glutathione peroxidase in ulcerative colitis patients.

Effect of saffron supplementation on oxidative stress markers (MDA, TAC, TOS, GPx, SOD, and pro-oxidant/antioxidant balance): An updated systematic review and meta-analysis of randomized placebo-controlled trials

Frontiers in Medicine | A. Abedi et al. | 3 | 2023

Meta Analysis

Saffron consumption significantly decreases MDA and TOS levels and increases TAC and GPx levels, helping maintain balanced oxidation levels.

The effect of saffron (Crocus sativus L.) on glycemia, lipid profile, and antioxidant status in patients with type‐2 diabetes mellitus: A randomized placebo‐controlled trial

Phytotherapy Research | A. Tajaddini et al. | 5 | 2022

Randomized Control Trial (RCT)

Saffron supplementation can improve oxidative status by reducing nitric oxide and malondialdehyde levels in patients with type-2 diabetes mellitus.

The role of Safranal and saffron stigma extracts in oxidative stress, diseases and photoaging: A systematic review

Heliyon | S. Nanda et al. | 28 | 2021

Systematic Review

Safranal, a major component of saffron, has immense antioxidant potential and is used as a therapeutic agent in various diseases.

Reviewed by Experts

Reviewed by the Scientific Advisory Board

Every research snapshot is checked by our independent Scientific Advisory Board: physicians, botanists and pharmacology researchers who verify the evidence grading and its interpretation.

Kerry Hughes

M.Sc., RH(AHG), FDN-P

Ethnobotanist & herbalist; Berkeley Herbal Center; principal at EthnoPharm.

View full profile →
Lance Dreher

PhD, Nutritional Counseling

Performance nutrition & conditioning; four decades of applied training science.

View full profile →
Dr. Lindsey Faucette

DO, FAAFP

Board-certified in Family & Integrative Medicine; Touro University College of Osteopathic Medicine.

View full profile →
Francisco Chacon

PhD, Plant Biology

Botanical natural products & phytochemistry researcher, Penn State University.

View full profile →

How We Grade Consensus

For each benefit we retrieve the relevant peer-reviewed literature and classify every study by whether its findings support (Yes), partially or conditionally support (Possibly), or do not support (No) the claim. The donut shows the share of studies in each category; N is the number of studies analyzed for that benefit.

Grades reflect the weight and direction of the current evidence, not a guarantee of outcome, and the interpretation is verified by the Scientific Advisory Board.

Data sourced from published, peer-reviewed research. Citations link to the original studies. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Last reviewed Jul 2026 · Meet the Scientific Advisory Board.